RobertoACalleMDFACE, FACP
Endocrinology • Tarrytown, NYDiabetes, Lipid Metabolism, Obesity
Executive Medical Director
Dr. Calle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Regeneron Pharmaceuticals
777 Old Sawmill River Road
Tarrytown, NY 10591
Education & Training
Yale-New Haven Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1989
University of MichiganResidency, Internal Medicine, 1984 - 1987
University of Puerto Rico School of MedicineClass of 1984, MD
Awards, Honors, & Recognition
- Alpha Omega Alpha Honor Medical Society 1983
Publications & Presentations
PubMed
- 30 citationsFibroblast Growth Factor 21 Improves Insulin Sensitivity and Synergizes with Insulin in Human Adipose Stem Cell-Derived (hASC) AdipocytesDarwin V. Lee, Dongmei Li, Qingyun Yan, Yimin Zhu, Bryan Goodwin
Plos One. 2014-11-03 - 19 citationsEffects of a long-acting GLP-1 mimetic (PF-04603629) on pulse rate and diastolic blood pressure in patients with type 2 diabetes mellitus.Stephanie M. Gustavson, D. Chen, Veena Somayaji, K. Hudson, Daniel Baltrukonis
Diabetes, Obesity & Metabolism. 2011-11-01 - 101 citationsOnce-weekly administration of a long-acting fibroblast growth factor 21 analogue modulates lipids, bone turnover markers, blood pressure and body weight differently in...Albert M. Kim, Veena Somayaji, Jennifer Q. Dong, Timothy P. Rolph, Yan Weng
Diabetes, Obesity & Metabolism. 2017-12-01
Journal Articles
- A First-In-Patient (Phase Ib) Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and CachexiaJ. Crawford, R.A. Calle, S.M. Collins, Y. Weng, Shannon L. Lubaczewski, C. Buckridge, E. Q Wang, M.A. Harrington, A. Tarachandani, M.I. Rossulek, J.H Revkin., Clinical Cancer Research, 2023
- Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitisA. J. Sanyal, S.S. Shankar, K.P. Yates, J. Bolognese, E. Daly, C. A. Dehn, B. Neuschwander-Tetri, K. Kowdley, R. Vuppalanchi, C. Behling, J. Tonascia, A. Samir, C. Sir..., Nature Medicine, 2023
- Repeatability of MRI biomarkers in non-alcoholic fatty liver disease: the NIMBLE ConsortiumK. Fowler, S. Venkatesh, N. Obuchowski, M. Middleton, J. Chen, K. Pepin, J. Magnuson, K. Brown, D. Batakis, W. Henderson, S. Shankar, T. Kamphaus, A. Pasek, R. Calle, ..., Radiology, 2023
- Join now to see all
Committees
- Co-Chair, Non-Invasive Biomarkers of Metabolic Liver Disease - NIMBLE FNIH Project 2018 - Present
- Member, American Diabetes Association New England - Community Leaders Board 2017 - Present
- Co-Chair, FNIH Biomarkers Consortium - Metabolic Disorders Steering Committee 2014 - Present
- Member, FNIH Biomarkers Consortium - Metabolic Disorders Steering Committee 2009 - 2013
Professional Memberships
- Fellow
- Member
- Member
- Fellow
- Member
Other Languages
- French, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
